Cingulate Inc.

New Filing
CIK: 0001862150·Pharmaceuticals·DELAWARE·Filed: Sep 28, 2021
Total Offering

$220,000,000

Amount Sold

$0

Investors

0

First Sale

N/A

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
Yes

Related Persons

NameRole
Gregg Givens
Related Person
Curt Medeiros
Related Person
Shane J Schaffer
Related Person
Patrick Gallagher
Related Person
Jeff Hargroves
Related Person
Peter J Werth
Related Person
Jeff Conroy
Related Person

Company

Cingulate Inc.

1901 W. 47TH PLACE

KANSAS CITY, KS, 66205

(913) 942-2300

SEC Filing

0000905718-21-001237

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cingulate Inc. Form D Filing — $220,000,000 | FilingFlow